Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chronic heart failure with preserved ejection fraction

N Martin, K Manoharan, C Davies… - Cochrane Database of …, 2021 - cochranelibrary.com
Background Beta‐blockers and inhibitors of the renin‐angiotensin‐aldosterone system
improve survival and reduce morbidity in people with heart failure with reduced left …

Effect of omega-3 on brain natriuretic peptide and echocardiographic findings in heart failure: Double-blind placebo-controlled randomized trial

J Kojuri, MA Ostovan, GR Rezaian, PA Dialameh… - Journal of …, 2013 - Elsevier
Background Possible beneficial effects of dietary omega-3 supplementation on patients with
congestive heart failure (CHF) were investigated. Methods and results 100 patients with …

Myocardial tissue engineering: the quest for the ideal myocardial substitute

EC Martinez, T Kofidis - Expert review of cardiovascular therapy, 2009 - Taylor & Francis
There has been an intense and competitive quest to manufacture bioartificial heart muscle in
the last decade. Numerous biocompatible scaffolds and scaffold-free systems, enriched with …

[HTML][HTML] Provision of palliative care for chronic heart failure inpatients: how much do we need?

R Harding, T Beynon, F Hodson, E Coady… - BMC palliative …, 2009 - Springer
Background Clinical guidance recommends early CHF palliative care intervention, but the
magnitude of need is unknown and evidence-based referral criteria absent. This study …

Engineered heart tissue graft derived from somatic cell nuclear transferred embryonic stem cells improve myocardial performance in infarcted rat heart

S Lü, Y Li, S Gao, S Liu, H Wang, W He… - Journal of Cellular …, 2010 - Wiley Online Library
The concept of regenerating diseased myocardium by implanting engineered heart tissue
(EHT) is intriguing. Yet it was limited by immune rejection and difficulties to be generated at …

Palliative medicine and advanced incurable illness

J Gaertner, S Simon, R Voltz - Der Internist, 2011 - Springer
Fortgeschrittene, nicht heilbare und lebenslimitierende internistische Erkrankungen wie die
chronisch obstruktive Lungenerkrankung (COPD), Herzinsuffizienz und terminale …